Biotech Investor

Biotech investment is one of the exciting spaces in the stock market. The companies in this sector focus on clinical research and development of new drugs. There is tremendous potential for stocks to deliver outstanding gains when companies report positive trial data or when their drugs obtain FDA approval.

The challenge comes when identifying stocks with enormous potential, and tracking various stages of drug development and the regulatory process is not easy. For instance, pending clinical trial/regulatory catalysts, FDA and its regulatory processes, phases of drug development and scheduled dates of important events can be hard to track from multiple sources of data.

Subscribers benefit from RTTNews team’s more than 2 decades of experience in covering biotech and pharmaceutical industry. Not only that a dedicated team at RTTNews traces these companies and developments, we help you identify stocks in this sector with strong fundamentals. We also help subscribers keep abreast of important events at these companies including IPO, daily news and developments, etc.

However, RTTNews does not offer any buy/sell, entry/exit recommendations, or target price for any stocks that we feature.

As with any good investment, timing determines the level of return. As a subscriber, you will have access to all the timely news, time-sensitive information, and alerts that can enable you to make sound investment decisions.

7-Day Free Trial (No Credit Card Required)

Login Subscribe

                        Features
                        
                        doneLimited Time Offer $299 $199 /month after your 7-Day FREE Trial ends.
done Save 25% OR $149 /month with Annual Subscription.
done Unlimited Access across any device (mobile/desktop).
done Informative Email Alerts featuring important news.
done Unlimited ad-free access.

                    

                        
                    

                       How subscribing to Biotech Investor will help you?
                        chevron_rightkeyboard_arrow_downFDA Calendar
PDUFA dates and FDA Panel Review dates are very important catalysts because they are ‘make or break events’ for biotech stocks. The FDA calendar covers large cap, mid cap, and small cap stocks with pending regulatory catalysts.
chevron_rightkeyboard_arrow_downClinical Trial Calendar
Clinical trials are binary speculative events that could make or break biotech stocks. Therefore, knowing the timing of announcement of results for phase I, phase II and phase III clinical studies helps limit risk and maximize profits when trading/investing in biotech stocks.
chevron_rightkeyboard_arrow_downNews Impacting Biotech Stocks
This service covers corporate announcements or updates from healthcare companies listed on the Nasdaq as well as NYSE.
chevron_rightkeyboard_arrow_downBiotech Stocks On The Move
Any major events or announcements made overnight or before and during the regular trading session can move the stock price. Sometimes, big stock movements are witnessed on no news. Our Biotech Stocks On The Move service helps subscribers gauge the direction of the stock.
chevron_rightkeyboard_arrow_downUpcoming Events
Annual meetings organized by American Society Of Clinical Oncology (ASCO) and American Society of Hematology (ASH); investor conferences like Goldman Sachs Annual Biotech Symposium, Morgan Stanley Global Healthcare Conference, Piper Jaffray Healthcare Conference and J. P. Morgan Healthcare Conference, to name a few; and regulatory events like FDA/panel announcements. These events can move the healthcare stocks.
chevron_rightkeyboard_arrow_downInvesting in Biotech and Pharma
RTT tracks and monitors hundreds of companies and potential market-moving events. These include pending new drug approvals, new FDA submissions, pending mid/early-stage clinical trial results, late-stage phase 3 clinical trial results, FDA advisory panel meetings and much more. 
chevron_rightkeyboard_arrow_downIPO Alert
This service provides news on upcoming healthcare IPOs.
chevron_rightkeyboard_arrow_downWeek Ahead In Pharma 
This weekly report lists events related to healthcare sector that could impact the stock price.
chevron_rightkeyboard_arrow_downIPO Lock-Up Expiration
An IPO lock-up expiration, which typically occurs 180 days from the first day of trading, is often associated with stock sell-off.
chevron_rightkeyboard_arrow_downLong-Term Stocks
In this service, you can access all information you need to know about stocks that have long-term investment potential.
chevron_rightkeyboard_arrow_downMake or Break Stocks 
This service alerts subscribers to stocks that have upcoming market-moving biotech events.
chevron_rightkeyboard_arrow_downThis Day That Year 
An overview of a company that has completed 1 year since its listing and the anticipated milestones.

                    

                        Biotech Investor Recent Articles.
                        
MiMedx Group Builds Momentum In Wound Care And Surgical Applications   12/15/2025 3:12 AM ET MiMedx Group Inc. (MDXG) has been steadily strengthening its position in advanced wound care and surgical applications, with recent clinical progress, regulatory developments, and financial growth underscoring its potential. Here's a closer look at what makes MiMedx a stock worth following. 

Company...

                                        Read More chevron_right
                                    
Is Now The Right Time To Take A Closer Look At Eton Pharmaceuticals?   12/11/2025 5:48 AM ET Eton Pharmaceuticals Inc. (ETON) stands out as a stock to monitor closely as the company continues to deliver strong commercial performance, expand its rare-disease portfolio, and advance multiple late-stage programs. With consistent revenue growth, increasing product adoption, and several regulatory...

                                        Read More chevron_right
                                    
Is Atara's Tab-Cel The Missing Piece In A Difficult-To-Treat Cancer?   12/11/2025 4:49 AM ET Atara Biotherapeutics Inc. (ATRA) has come into focus as a stock to watch following steady progress across its lead cell-therapy program, a major regulatory milestone approaching in early 2026, and a corporate restructuring that has significantly reduced operating expenses. The stock closed at $16.83,...

                                        Read More chevron_right
                                    
What's Next For Alpha Tau: Major Milestones Expected Through Early 2026   12/11/2025 2:57 AM ET Israeli oncology company Alpha Tau Medical Ltd. (DRTS) drew strong attention after the stock surged to a new 52-week high of $5.07 on December 10. It closed at $5.06, marking a 19.62% gain for the day, and extended its rise to $5.20 in after-hours trading. The strong price action comes at a time when...

                                        Read More chevron_right
                                    
Will ElectroCore's Performance Hold Steady As The Market Tests Its Resilience?   12/8/2025 2:32 AM ET electroCore Inc. (ECOR) is a bioelectronic technology company focused on advancing non-invasive neuromodulation therapies. Its mission is to improve health and quality of life through innovative devices that address chronic pain syndromes and promote wellness. With prescription products such as gammaCore...

                                        Read More chevron_right
                                    
Is EyePoint Poised To Open New Eyes In Retinal Disease Care?   12/5/2025 12:40 AM ET EyePoint Pharmaceuticals Inc. (EYPT) has stepped into the spotlight after reaching a new 52-week high on Thursday, December 4, 2025. The company's late-stage clinical programs and strengthened financial position have placed it firmly in focus as one to watch in the ophthalmology space.

Strong Move...

                                        Read More chevron_right

Frequently Asked Questions

Where do I login to access Biotech Investor / Premium Services ?
Go to the following link to login and view your subscription https://www.rttnews.com/products/login.aspx
In order to change payment details or personal details, login to the following link
https://products.rttnews.com/signin.aspx.

By what methods can I pay ?
You can pay via Credit Card or Paypal account. Credit Card or Paypal account should be updated on or before the day your 7-Day FREE Trial ends.

What is the subscription fees ?
Limited Time Offer $299 $199 /month after your 7-Day FREE Trial ends.

Is a Credit Card required for FREE Trial Subscription ?
No, you can sign up for our 7-Day FREE Trial subscription without entering your credit card / payment details.

My Email Address shows as already registered. How do I Sign up ?
If you would like to subscribe using an already registered email address, kindly contact us.

How do I subscribe for Annual Subscription ?
If you would like to subscribe for annual subscription, kindly contact us.
Terms & Conditions

All of the free and premium services offered on RTTNews.com are provided for information purposes only. None of the information or opinions expressed in any of our services should be construed as an offer or solicitation to buy or sell, or as an endorsement, recommendation of any securities, options, futures or funds. We are not investment advisors and we do not provide personalized advice. If you need personal advice, then you should seek the advice of a qualified investment advisor.

All our services are designed to help you save time with your investment research. RTTNews does not warrant the reliability or completeness or accuracy of the Content found in our Services or its usefulness for any particular purpose. You are responsible for your own investment decisions. RTTNews will not be liable for any direct, indirect, incidental or any other type of loss or damages caused by a reader's reliance on information obtained on our site.

Please read our Terms and Conditions of service for complete terms.

Follow us